Health Maintenance in Postmenopausal Women

Monica Plesa, MD
Anita Wong, MD
Ereni Katsaggelos, MD, MS

American Family Physician. 2025;111(5):407-418.

Author disclosure: No relevant financial relationships.

This clinical content conforms to AAFP criteria for CME.

There are unique considerations for preventive care in postmenopausal women. Cardiovascular disease is the leading cause of death for women in the United States, and postmenopausal women should be routinely screened for risk factors such as diabetes, hypertension, and dyslipidemia. Atherosclerotic cardiovascular disease 10-year risk scores should be calculated to guide management of risk factors, including lifestyle changes and medications, particularly statins. Average-risk women should be screened for breast cancer with mammography every 1 to 2 years starting at age 40 years. Lung cancer screening with low-dose computed tomography should be offered annually to current and former smokers aged 50 to 80 years with at least a 20-pack-year history. Colorectal cancer screening is recommended in average-risk women aged 45 to 75 years. Cervical cancer screening should be performed every 3 to 5 years, and it should be discontinued in women older than 65 years with negative results on adequate prior screening. Average-risk women 65 years and older should be screened for osteoporosis with dual-energy x-ray absorptiometry. The diagnosis of osteoporosis is based on a T-score of −2.5 or less, and those with a Fracture Risk Assessment Tool score of 3% or greater for hip fracture or 20% or greater for any major osteoporotic fracture should be treated. Postmenopausal women should be routinely screened for high-risk sexual behavior, HIV, hepatitis, depression, anxiety, and substance use disorders.

MONICA PLESA, MD, is an associate professor in the Department of Family Medicine at the David Geffen School of Medicine at the University of California, Los Angeles.

ANITA WONG, MD, is an assistant professor in the Department of Family Medicine at the David Geffen School of Medicine at the University of California.

ERENI KATSAGGELOS, MD, MS, is an assistant professor in the Department of Family Medicine at the David Geffen School of Medicine at the University of California.

Address correspondence to Monica Plesa, MD, at mplesa@mednet.ucla.edu.

Author disclosure: No relevant financial relationships.

  1. 1.National Institute on Aging. What is menopause? Accessed November 19, 2024. https://www.nia.nih.gov/health/menopause/what-menopause
  2. 2.Martin SS, Aday AW, Almarzooq ZI, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024;149(8):e347-e913.
  3. 3.Curtin SC, Tejada-Vera B, Bastian BA. Deaths: leading causes for 2021. National Center for Health Statistics; 2024. Accessed April 27, 2024. https://www.cdc.gov/nchs/data/nvsr/nvsr73/nvsr73-04.pdf
  4. 4.Cho L, Davis M, Elgendy I, et al.; ACC CVD Womens Committee Members. Summary of updated recommendations for primary prevention of cardiovascular disease in women: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(20):2602-2618.
  5. 5.Keteepe-Arachi T, Sharma S. Cardiovascular disease in women: understanding symptoms and risk factors. Eur Cardiol. 2017;12(1):10-13.
  6. 6.Carland C, Hansra B, Parsons C, et al. Adequate enrollment of women in cardiovascular drug trials and the need for sex-specific assessment and reporting. Am Heart J Plus. 2022;17:100155.
  7. 7.Davidson KW, Barry MJ, Mangione CM, et al. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement. JAMA. 2021;326(8):736-743.
  8. 8.American Academy of Family Physicians. Clinical preventive service recommendation: diabetes screening, adults. 2021. Accessed April 28, 2024. https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/diabetes-screening-adults.html
  9. 9.American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025. Diabetes Care. 2025;48(suppl 1):S27-S49.
  10. 10.Mangione CM, Barry MJ, Nicholson WK, et al. Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement. JAMA. 2022;328(8):746-753.
  11. 11.Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):e177-e232.
  12. 12.James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520.
  13. 13.Murthy GD. The JNC 7 hypertension guidelines. JAMA. 2003;290(10):1313.
  14. 14.Krist AH, Davidson KW, Mangione CM, et al.; US Preventive Services Task Force. Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA. 2021;325(16):1650-1656.
  15. 15.Curry SJ, Krist AH, Owens DK, et al.; US Preventive Services Task Force. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(11):1163-1171.
  16. 16.US Preventive Services Task Force. Healthy diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: behavioral counseling interventions. July 26, 2022. Accessed May 7, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-lifestyle-and-physical-activity-for-cvd-prevention-adults-without-known-risk-factors-behavioral-counseling
  17. 17.Jensen MD, Ryan DH, Apovian CM, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Obesity Society. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J Am Coll Cardiol. 2014;63(25 pt B):2985-3023.
  18. 18.ACOG committee opinion no. 763: ethical considerations for the care of patients with obesity. Obstet Gynecol. 2019;133(1):e90-e96.
  19. 19.Krist AH, Davidson KW, Mangione CM, et al.; US Preventive Services Task Force. Interventions for tobacco smoking cessation in adults, including pregnant persons: US Preventive Services Task Force recommendation statement. JAMA. 2021;325(3):265-279.
  20. 20.Bertomeu-Gonzalez V, Cordero A, Ruiz-Nodar JM, et al. Risk factors for major adverse cardiovascular events in postmenopausal women: UK Biobank prospective cohort study. Atherosclerosis. 2023;386:117372.
  21. 21.Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):3168-3209.
  22. 22.Davidson KW, Barry MJ, Mangione CM, et al.; US Preventive Services Task Force. Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. JAMA. 2022;327(16):1577-1584.
  23. 23.ACOG practice bulletin no. 141: management of menopausal symptoms. Obstet Gynecol. 2014;123(1):202-216.
  24. 24.Mangione CM, Barry MJ, Nicholson WK, et al. Hormone therapy for the primary prevention of chronic conditions in postmenopausal persons: US Preventive Services Task Force recommendation statement. JAMA. 2022;328(17):1740-1746.
  25. 25.American Cancer Society. Recommendations for the early detection of breast cancer. December 19, 2023. Accessed April 21, 2024. https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html
  26. 26.Pearlman M, Jeudy M, Chelmow D; American College of Obstetricians and Gynecologists Committee on Practice Bulletins. July 2017. Practice bulletin no. 179: breast cancer risk assessment and screening in average-risk women. Accessed April 20, 2024. https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2017/07/breast-cancer-risk-assessment-and-screening-in-average-risk-women
  27. 27.Age to initiate routine breast cancer screening: ACOG clinical practice update. Obstet Gynecol. 2025;145(1):e40-e44.
  28. 28.National Comprehensive Cancer Network. Breast cancer screening and diagnosis (version 1). 2025. Accessed March 11, 2025. https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdf
  29. 29.US Preventive Services Task Force. Screening for breast cancer. April 30, 2024. Accessed May 1, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/breast-cancer-screening-final-rec-bulletin.pdf
  30. 30.Agrawal P, Audet CM, Ernst LL, et al. Next top model: an overview of breast cancer risk assessment models. Appl Radiol. 2024(1):8-15.
  31. 31.US Preventive Services Task Force. Breast cancer: medication use to reduce risk. September 3, 2019. Accessed April 21, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction
  32. 32.US Preventive Services Task Force. Ovarian cancer: screening. February 13, 2018. Accessed April 21, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/ovarian-cancer-screening
  33. 33.US Preventive Services Task Force. Lung cancer: screening. March 9, 2021. Accessed April 21, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening
  34. 34.Wolf AMD, Oeffinger KC, Shih TYC, et al. Screening for lung cancer: 2023 guideline update from the American Cancer Society. 2024;74(1):50-81.
  35. 35.US Preventive Services Task Force. Colorectal cancer: screening. May 18, 2021. Accessed April 21, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening
  36. 36.Shaukat A, Kahi CJ, Burke CA, et al. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021;116(3):458-479.
  37. 37.US Preventive Services Task Force. Cervical cancer: screening. December 10, 2024. Accessed December 11, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/cervical-cancer-screening-adults-adolescents
  38. 38.American College of Obstetricians and Gynecologists. Updated cervical cancer screening guidelines. April 2021. Accessed April 21, 2024. https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/04/updated-cervical-cancer-screening-guidelines
  39. 39.US Preventive Services Task Force. Osteoporosis to prevent fractures: screening. January 14, 2025. Accessed March 10, 2025. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
  40. 40.Osteoporosis prevention, screening, and diagnosis: ACOG clinical practice guideline no. 1. Obstet Gynecol. 2021;138(3):494-506.
  41. 41.LeBoff MS, Greenspan SL, Insogna KL, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33(10):2049-2102.
  42. 42.Gourlay ML, Fine JP, Preisser JS, et al.; Study of Osteoporotic Fractures Research Group. Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med. 2012;366(3):225-233.
  43. 43.US Preventive Services Task Force. Vitamin D, calcium, or combined supplementation for the primary prevention of falls and fractures in community-dwelling adults: preventive medication. December 17, 2024. Accessed March 10, 2025. https://www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/vitamin-d-calcium-combined-supplementation-primary-prevention-falls-fractures-communitydwelling-adults#fullrecommendationstart
  44. 44.US Preventive Services Task Force. Impaired visual acuity in older adults: screening. May 24, 2022. Accessed April 20, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/impaired-visual-acuity-screening-older-adults
  45. 45.US Preventive Services Task Force. Hearing loss in older adults: screening. March 23, 2021. Accessed April 20, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hearing-loss-in-older-adults-screening
  46. 46.US Preventive Services Task Force. Unhealthy alcohol use in adolescents and adults: screening and behavioral counseling interventions. November 13, 2018. Accessed April 22, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions
  47. 47.US Preventive Services Task Force. Anxiety disorders in adults: screening. June 20, 2023. Accessed April 22, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/anxiety-adults-screening
  48. 48.US Preventive Services Task Force. Depression and suicide risk in adults: screening. June 20, 2023. Accessed April 22, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults
  49. 49.US Preventive Services Task Force. Unhealthy drug use: screening. June 9, 2020. Accessed April 22, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-screening
  50. 50.US Preventive Services Task Force. Hepatitis B virus infection in adolescents and adults: screening. December 15, 2020. Accessed June 4, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-b-virus-infection-screening
  51. 51.US Preventive Services Task Force. Hepatitis C virus infection in adolescents and adults: screening. March 2, 2020. Accessed June 4, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening
  52. 52.US Preventive Services Task Force. Sexually transmitted infections: behavioral counseling. August 18, 2020. Accessed April 22, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/sexually-transmitted-infections-behavioral-counseling
  53. 53.Centers for Disease Control and Prevention. Discussing sexual health with your patients. February 10, 2025. Accessed March 10, 2025. https://www.cdc.gov/hivnexus/hcp/sexual-history/index.html
  54. 54.US Preventive Services Task Force. Human immunodeficiency virus (HIV) infection: screening. June 11, 2019. Accessed November 30, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening
  55. 55.Centers for Disease Control and Prevention. STI statistics. Accessed April 20, 2024. https://www.cdc.gov/sti-statistics/?CDC_AAref_Val=https://www.cdc.gov/std/statistics/2022/2021-STD-surveillance-report-pdf_archived-2-16-24.pdf
  56. 56.Micks E. Sexually transmitted infections in midlife women. Menopause. 2024;31(5):430-432.
  57. 57.US Preventive Services Task Force. Cognitive impairment in older adults: screening. February 25, 2020. Accessed November 30, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/cognitive-impairment-in-older-adults-screening
  58. 58.Centers for Disease and Control and Prevention. Hepatitis B surveillance guidance. Accessed June 4, 2024. https://www.cdc.gov/hepatitis/statistics/surveillanceguidance/HepatitisB.htm
  59. 59.Centers for Disease and Control and Prevention. Drug & alcohol deaths on the rise among older Americans. November 30, 2022. Accessed April 22, 2024. https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20221130.htm
  60. 60.Hall JE, Karch DL, Crosby AE. Elder abuse surveillance: uniform definitions and recommended core data elements for use in elder abuse surveillance, version 1.0. National Center for Injury Prevention and Control; 2016. Accessed March 10, 2025. https://stacks.cdc.gov/view/cdc/37909
  61. 61.US Preventive Services Task Force. Intimate partner violence, elder abuse, and abuse of vulnerable adults: screening. October 23, 2018. Accessed April 22, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening
  62. 62.Centers for Disease and Control and Prevention. Vaccine-specific recommendations. January 7, 2025. Accessed March 10, 2025. https://www.cdc.gov/acip-recs/hcp/vaccine-specific/?CDC_AAref_Val=https://www.cdc.gov/vaccines/hcp/acip-recs/index.html
  63. 63.Baill IC, Castiglioni A. Health maintenance in postmenopausal women. Am Fam Physician. 2017;95(9):561-570.
  64. 64.Rao SS, Singh M, Parkar M, et al. Health maintenance for postmenopausal women. Am Fam Physician. 2008;78(5):583-591.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.